{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T15:59:49Z","timestamp":1762271989477},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.jpeds.2016.01.027","type":"journal-article","created":{"date-parts":[[2016,2,7]],"date-time":"2016-02-07T02:31:03Z","timestamp":1454812263000},"page":"151-155.e1","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Safety of Everolimus in Patients Younger than 3 Years of Age: Results from EXIST-1, a Randomized, Controlled\u00a0Clinical Trial"],"prefix":"10.1016","volume":"172","author":[{"given":"Sergiusz","family":"J\u00f3\u017awiak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Kotulska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noah","family":"Berkowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Brechenmacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David Neal","family":"Franz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2016.01.027_bib1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Northrup","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jpeds.2016.01.027_bib2","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1542\/peds.2010-0192","article-title":"Tuberous sclerosis complex: diagnostic challenges, presenting symptoms, and commonly missed signs","volume":"127","author":"Staley","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2016.01.027_bib3","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1468-1331.2009.02567.x","article-title":"Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature","volume":"16","author":"Adriaensen","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jpeds.2016.01.027_bib4","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0025-6196(12)61196-3","article-title":"Causes of death in patients with tuberous sclerosis","volume":"66","author":"Shepherd","year":"1991","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jpeds.2016.01.027_bib5","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1086\/316951","article-title":"Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs","volume":"68","author":"Dabora","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jpeds.2016.01.027_bib6","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s00381-002-0700-2","article-title":"Subependymal giant cell astrocytoma in children with tuberous sclerosis","volume":"19","author":"Cuccia","year":"2003","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.jpeds.2016.01.027_bib7","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1212\/01.WNL.0000142039.14522.1A","article-title":"Subependymal giant cell tumors in tuberous sclerosis complex","volume":"63","author":"Goh","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jpeds.2016.01.027_bib8","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1136\/adc.2005.081703","article-title":"Congenital subependymal giant cell astrocytoma diagnosed on fetal MRI","volume":"91","author":"Hussain","year":"2006","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jpeds.2016.01.027_bib9","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1007\/s00381-014-2555-8","article-title":"Congenital subependymal giant cell astrocytomas in patients with tuberous sclerosis complex","volume":"30","author":"Kotulska","year":"2014","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.jpeds.2016.01.027_bib10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00401-013-1085-x","article-title":"Evolving neurobiology of tuberous sclerosis complex","volume":"125","author":"Crino","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jpeds.2016.01.027_bib11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1227\/01.NEU.0000249216.19591.5D","article-title":"Subependymal giant-cell astrocytomas in pediatric tuberous sclerosis disease: when should we operate?","volume":"60","author":"de Ribaupierre","year":"2007","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jpeds.2016.01.027_bib12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","article-title":"Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Krueger","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jpeds.2016.01.027_bib13","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1185\/03007995.2012.658907","article-title":"Outcomes of resecting subependymal giant cell astrocytoma (SEGA) among patients with SEGA-related tuberous sclerosis complex: a national claims database analysis","volume":"28","author":"Sun","year":"2012","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jpeds.2016.01.027_bib14","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.pediatrneurol.2013.12.004","article-title":"Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients","volume":"50","author":"Kotulska","year":"2014","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jpeds.2016.01.027_bib15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","article-title":"Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial","volume":"381","author":"Franz","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jpeds.2016.01.027_bib16","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S1470-2045(14)70489-9","article-title":"Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study","volume":"15","author":"Franz","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jpeds.2016.01.027_bib17","doi-asserted-by":"crossref","first-page":"e239","DOI":"10.1542\/peds.2012-3607","article-title":"Possible prevention of tuberous sclerosis complex lesions","volume":"132","author":"Kotulska","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2016.01.027_bib18","doi-asserted-by":"crossref","first-page":"e1335","DOI":"10.1542\/peds.2010-2910","article-title":"Regression of a cardiac rhabdomyoma in a patient receiving everolimus","volume":"127","author":"Tiberio","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2016.01.027_bib19","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1097\/MPH.0000000000000005","article-title":"Response of subependymal giant cell astrocytoma with spinal cord metastasis to everolimus","volume":"36","author":"Aguilera","year":"2013","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jpeds.2016.01.027_bib20","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1007\/s00381-013-2170-0","article-title":"Successful everolimus therapy for SEGA in pediatric patients with tuberous sclerosis complex","volume":"29","author":"Cappellano","year":"2013","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.jpeds.2016.01.027_bib21","first-page":"303","article-title":"A formula to estimate the approximate surface area if height and weight be known. 1916","volume":"5","author":"Du Bois","year":"1989","journal-title":"Nutrition"},{"key":"10.1016\/j.jpeds.2016.01.027_bib22","series-title":"Afinitor (everolimus tablets for oral administration) Afinitor Disperz (everolimus tablets for oral suspension) [package insert]","year":"2015"},{"key":"10.1016\/j.jpeds.2016.01.027_bib23","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.pediatrneurol.2013.08.017","article-title":"Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012","volume":"49","author":"Roth","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jpeds.2016.01.027_bib24","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ejpn.2012.12.008","article-title":"Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): clinical recommendations","volume":"17","author":"Jozwiak","year":"2013","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.jpeds.2016.01.027_bib25","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ejpn.2013.03.002","article-title":"Long-term effect of everolimus on epilepsy and growth in children under 3 years of age treated for subependymal giant cell astrocytoma associated with tuberous sclerosis complex","volume":"17","author":"Kotulska","year":"2013","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.jpeds.2016.01.027_bib26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/ndt\/gfv249","article-title":"Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial","volume":"31","author":"Bissler","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jpeds.2016.01.027_bib27","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ejpn.2014.06.009","article-title":"Epilepsy in newborns with tuberous sclerosis complex","volume":"18","author":"Kotulska","year":"2014","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.jpeds.2016.01.027_bib28","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.ejca.2011.02.014","article-title":"Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma","volume":"47","author":"Porta","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jpeds.2016.01.027_bib29","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/petr.12261","article-title":"Three-year safety and efficacy of everolimus and low-dose cyclosporine in de novo pediatric kidney transplant patients","volume":"18","author":"Ferraresso","year":"2014","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jpeds.2016.01.027_bib30","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/petr.12147","article-title":"Growing experience with mTOR inhibitors in pediatric solid organ transplantation","volume":"17","author":"Ganschow","year":"2013","journal-title":"Pediatr Transplant"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347616000299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347616000299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T06:47:48Z","timestamp":1718347668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347616000299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":30,"alternative-id":["S0022347616000299"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2016.01.027","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of Everolimus in Patients Younger than 3 Years of Age: Results from EXIST-1, a Randomized, Controlled\u00a0Clinical Trial","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2016.01.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}